Neupro

Drug UCB, Inc.
Total Payments
$1.2M
Transactions
17,826
Doctors
2,956
Companies
3

Payment Trends by Year

Year Amount Transactions Doctors
2024 $37.77 1 1
2023 $12.72 2 2
2022 $3,274 166 139
2021 $55,485 3,023 974
2020 $171,595 2,009 723
2019 $240,368 3,748 1,077
2018 $283,821 3,779 1,153
2017 $426,365 5,098 1,597

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $534,755 450 45.3%
Food and Beverage $323,914 17,028 27.4%
Consulting Fee $235,081 32 19.9%
Travel and Lodging $36,913 291 3.1%
Space rental or facility fees (teaching hospital only) $33,250 16 2.8%
Unspecified $17,044 8 1.4%
Education $1.74 1 0.0%

Payments by Type

General
$1.2M
17,818 transactions
Research
$17,044
8 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of RA101495 UCB Biosciences Inc. $7,116 0
A MULTICENTER, OPEN LABEL, TWO-ARM STUDY TO EVALUATE THE IMPACT OF USING WEARABLE DEVICES IN ADDITION TO STANDARD CLINICAL PRACTICE ON PARKINSON'S SUBJECT SYMPTOMS MANAGEMENT - PHASE 4 UCB SA $5,323 1
Patient and physician perceptions of disease management in Parkinsons disease - Results from a US-based multicenter survey UCB, Inc. $4,600 2
A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects with Moderate to Severe Idiopathic Restless Legs Syndrome (RL0003) UCB Biosciences Inc. $5.00 0

Top Doctors Receiving Payments for Neupro — Page 4

Doctor Specialty Location Total Records
, MD,PHD Neurology Gilbert, AZ $691.42 56
, MD Specialist Flushing, NY $691.08 35
, MD Neurology Arcadia, CA $679.25 29
, MD Neurology Huntsville, AL $669.43 36
, M.D Epilepsy Arcadia, CA $669.16 23
, D.O Neurology Albertville, AL $656.84 40
, M.D Neurology Arcadia, CA $653.56 21
, MD Neurology Birmingham, AL $651.83 34
, M.D Neurology Plant City, FL $644.58 40
, MD Child & Adolescent Psychiatry Chandler, AZ $638.69 38
, M.D Neurology Forest Hills, NY $636.70 32
, MD Neurology St. Petersburg, FL $635.40 34
Milenko Lazarevic — Chicago, IL $627.83 35
, MD Neurology Leesburg, VA $623.71 32
, M.D., PH. D Neurology Tampa, FL $622.69 43
Andrew Ta — North Aurora, IL $621.62 28
, M.D Neurology San Marcos, TX $620.37 47
, M.D Neurology St Petersburg, FL $616.00 33
Santiago Restrepo Neurology San Antonio, TX $610.29 30
, M.D Neurology Washington, PA $605.89 32
, D.O Neurology St Petersburg, FL $593.01 33
, M.D Specialist Kensington, MD $583.75 34
, MD Neurology Sarasota, FL $580.77 41
, MD Neurology Newton, NJ $570.34 42
Richard Kasdan — Pittsburgh, PA $569.06 35
«123456…119»

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $1.2M
  • Total Doctors 2,956
  • Transactions 17,826

About Neupro

Neupro is a drug associated with $1.2M in payments to 2,956 healthcare providers, recorded across 17,826 transactions in the CMS Open Payments database. The primary manufacturer is UCB, Inc..

Payment data is available from 2017 to 2024. In 2024, $37.77 was paid across 1 transactions to 1 doctors.

The most common payment nature for Neupro is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($534,755, 45.3% of total).

Neupro is associated with 4 research studies, including "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of RA101495" ($7,116).